These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30883363)

  • 41. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New DSM-V neurocognitive disorders criteria and their impact on diagnostic classifications of mild cognitive impairment and dementia in a memory clinic setting.
    Tay L; Lim WS; Chan M; Ali N; Mahanum S; Chew P; Lim J; Chong MS
    Am J Geriatr Psychiatry; 2015 Aug; 23(8):768-79. PubMed ID: 25728011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mild cognitive impairment and dementia in primary care: the value of medical history.
    Olazarán J; Torrero P; Cruz I; Aparicio E; Sanz A; Mula N; Marzana G; Cabezón D; Begué C
    Fam Pract; 2011 Aug; 28(4):385-92. PubMed ID: 21402661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for Mild Cognitive Impairment Using the Dementia Rating Scale-2.
    Springate BA; Tremont G; Papandonatos G; Ott BR
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):139-44. PubMed ID: 24578462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Utility of the Envelope Task in Mild Cognitive Impairment and Dementia.
    Marcone S; Gagnon JF; Lecomte S; Imbeault H; Limoges F; Postuma RB; Bertrand JA; Joubert S; Rouleau I
    Can J Neurol Sci; 2017 Jan; 44(1):9-16. PubMed ID: 27665668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
    Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
    Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The AD8 (Dementia Screening Interview) is a valid and reliable screening scale not only for dementia but also for mild cognitive impairment in the Turkish geriatric outpatients.
    Usarel C; Dokuzlar O; Aydin AE; Soysal P; Isik AT
    Int Psychogeriatr; 2019 Feb; 31(2):223-229. PubMed ID: 29923472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MACE for the Diagnosis of Dementia and MCI: 3-Year Pragmatic Diagnostic Test Accuracy Study.
    Williamson JC; Larner AJ
    Dement Geriatr Cogn Disord; 2018; 45(5-6):300-307. PubMed ID: 29996145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-Density Lipoprotein Subclasses and Mild Cognitive Impairment: Study of Outcome and aPolipoproteins in Dementia (STOP-Dementia)1.
    Ohtani R; Nirengi S; Nakamura M; Murase N; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Kotani K; Sakane N
    J Alzheimers Dis; 2018; 66(1):289-296. PubMed ID: 30248050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of the Spanish version of the Everyday Cognition scale in the diagnosis of mild cognitive impairment and mild dementia in an older cohort from the Argentina-ADNI.
    Russo MJ; Cohen G; Chrem Mendez P; Campos J; Martín ME; Clarens MF; Tapajoz F; Harris P; Sevlever G; Allegri RF
    Aging Clin Exp Res; 2018 Oct; 30(10):1167-1176. PubMed ID: 29380265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. General practitioners and general practice registrars: A comparison of clinical activity.
    Gordon J; Harrison C; Miller G
    Aust Fam Physician; 2016 May; 45(5):263-5. PubMed ID: 27166457
    [No Abstract]   [Full Text] [Related]  

  • 52. Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway.
    Strand BH; Knapskog AB; Persson K; Edwin TH; Amland R; Mjørud M; Bjertness E; Engedal K; Selbæk G
    PLoS One; 2018; 13(9):e0204436. PubMed ID: 30240425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Efficacy of General Practitioner Assessment of Cognition in Chinese Elders Aged 80 and Older.
    Xu F; Ma JJ; Sun F; Lee J; Coon DW; Xiao Q; Huang Y; Zhang L; Liang ZH
    Am J Alzheimers Dis Other Demen; 2019; 34(7-8):523-529. PubMed ID: 31266345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dementia assessment and management in primary care settings: a survey of current provider practices in the United States.
    Bernstein A; Rogers KM; Possin KL; Steele NZR; Ritchie CS; Kramer JH; Geschwind M; Higgins JJ; Wohlgemuth J; Pesano R; Miller BL; Rankin KP
    BMC Health Serv Res; 2019 Nov; 19(1):919. PubMed ID: 31783848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subtle changes in daily functioning predict conversion from normal to mild cognitive impairment or dementia: an analysis of the NACC database.
    Nowrangi MA; Rosenberg PB; Leoutsakos JS
    Int Psychogeriatr; 2016 Dec; 28(12):2009-2018. PubMed ID: 27585497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comorbid Mild Cognitive Impairment and Depressive Symptoms Predict Future Dementia in Community Older Adults: A 24-Month Follow-Up Longitudinal Study.
    Makizako H; Shimada H; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Makino K; Suzuki T
    J Alzheimers Dis; 2016 Oct; 54(4):1473-1482. PubMed ID: 27589518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults.
    Mortby ME; Ismail Z; Anstey KJ
    Int Psychogeriatr; 2018 Feb; 30(2):221-232. PubMed ID: 28931446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia.
    Viticchi G; Falsetti L; Buratti L; Sajeva G; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2017; 59(1):67-75. PubMed ID: 28582863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.